Skip to main content
SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD logo

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD — Investor Relations & Filings

Ticker · 688389 ISIN · CNE100005WZ5 Shanghai Stock Exchange Manufacturing
Filings indexed 812 across all filing types
Latest filing 2025-08-28 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 688389

About SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD

https://en.lifotronic.com/

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD. specializes in the research, development, and manufacturing of medical equipment for therapeutic and diagnostic applications. The company’s therapeutic portfolio includes negative pressure wound therapy (NPWT) systems, high-frequency chest wall oscillation devices for airway clearance, and various physical therapy and rehabilitation solutions. In the field of in-vitro diagnostics, it offers high-performance liquid chromatography (HPLC) hemoglobin analyzers for diabetes management and chemiluminescence immunoassay (CLIA) platforms. Lifotronic integrates advanced engineering with clinical requirements to provide solutions for wound care, respiratory health, and laboratory testing. The company serves a global market, focusing on technological innovation and the delivery of precise, reliable medical instruments designed to improve patient outcomes across diverse clinical settings.

Recent filings

Filing Released Lang Actions
深圳普门科技股份有限公司2025年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2025 年半年度报告摘要" which translates to "2025 Semi-Annual Report Summary." It contains detailed financial data for the first half of 2025, including total assets, net profit, revenue, and other key financial metrics. It also includes shareholder information and risk disclosures. The document explicitly states it is a summary of the half-year report and advises investors to read the full semi-annual report for comprehensive details. The length is 3272 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a link to a report. The content aligns with an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year and includes actual financial statements and management discussion. Therefore, the correct classification is IR (Interim / Quarterly Report).
2025-08-28 Chinese
深圳普门科技股份有限公司2025年度“提质增效重回报”行动方案的半年度评估报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2025年度“提质增效重回报”行动方案 的半年度评估报告' which translates to a '2025 Annual "Quality Improvement, Efficiency Enhancement, and Return" Action Plan Half-Year Assessment Report.' It contains detailed operational and financial performance data for the first half of 2025, including revenue, net profit, R&D expenses, governance updates, investor communication, and dividend information. The document is comprehensive and covers a half-year period with substantive financial data and management discussion. It is not a full annual report but a mid-year comprehensive report with financial and operational analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length (6039 characters) supports it being a substantive report rather than a brief announcement. There is no indication that this is a mere announcement or certification, nor is it a transcript, audit report, or other specific category. Hence, the best classification is IR with high confidence.
2025-08-28 Chinese
深圳普门科技股份有限公司关于签订房屋租赁合同暨关联交易的公告
Regulatory Filings Classification · 100% confidence The document is an announcement by Shenzhen Pumen Technology Co., Ltd. regarding the signing of a house lease contract with a related party, Mr. Liu Xiancheng, who is the controlling shareholder and chairman of the company. The announcement details the terms of the lease, the relationship between the parties, the pricing, the approval process by the board and independent directors, and the legal and financial implications. It is a regulatory announcement about a related party transaction involving leasing property for company use. There is no financial statement, earnings data, or report attached or referenced as being published. The document is not a full financial report, audit report, or earnings release. It is a formal disclosure of a related party transaction and its approval process, which fits best under the category of Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit other more specific categories.
2025-08-28 Chinese
深圳普门科技股份有限公司2025年半年度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled "深圳普门科技股份有限公司2025年半年度报告" which translates to "Shenzhen Lifotronic Technology Co., Ltd. 2025 Semi-Annual Report." It contains detailed financial data for the first half of 2025, including revenue, profit, cash flow, earnings per share, and non-recurring items. It also includes management discussion and analysis, company background, industry overview, and risk factors. The length is substantial (15,000 characters) and the content includes actual financial statements and substantive financial analysis for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). It is not an announcement or a brief summary, nor is it a full annual report (10-K). Therefore, the correct classification is IR with high confidence.
2025-08-28 Chinese
深圳普门科技股份有限公司关于召开2025年半年度业绩说明会的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen Pumen Technology Co., Ltd. about the scheduling of a 2025 semi-annual performance briefing meeting (业绩说明会). It specifies the date, time, location, and format of the meeting, as well as instructions for investor participation and question submission. It also mentions that the company will disclose its 2025 semi-annual report on August 29, 2025, but this document itself does not contain the report or financial data. The document is short (1504 characters) and serves as a notice for an upcoming event rather than the report or transcript itself. Therefore, it fits the category of an Investor Presentation announcement or a meeting notice. However, since it is specifically about the scheduling of a performance briefing meeting and not the presentation materials themselves, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the meeting and not the actual report or transcript. It is not a full Interim/Quarterly Report (IR) because it lacks substantive financial data, nor is it a Call Transcript (CT) since the meeting has not yet occurred. It is not an AGM Information (AGM-R) because it is not an annual general meeting but a semi-annual performance briefing. Hence, the most appropriate classification is Regulatory Filings (RNS).
2025-08-25 Chinese
深圳普门科技股份有限公司关于自愿披露取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure announcement by Shenzhen Pumen Technology Co., Ltd. regarding the receipt of a medical device registration certificate issued by the Guangdong Provincial Drug Administration. It details the product name, registration classification, certificate number, validity period, and intended use. The document also discusses the impact of this registration on the company and includes a risk warning about the uncertainty of future sales impact. The document is short (1023 characters) and serves as an official announcement of a regulatory approval rather than a financial report or detailed management discussion. It does not contain financial data, earnings, or management changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-22 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.